Abstract Library

#4570 Diagnosis of carcinoid heart disease continues to be late delayed

Introduction: Carcinoid heart disease (CHD) is a serious complication of neuroendocrine tumours. It affects patients with carcinoid syndrome and results from fibrotic deposits on the heart valves. It significantly impacts patient prognosis.

Conference:

Presenting Author:

Authors: Sharma J, Shah T, Coldham C, Vickrage S, Rehman Z,

Keywords: carcinoid syndrome, neuroendocrine tumour, carcinoid heart disease, symptoms, presentation, echocardiogram, heart valves,

#3549 Patient characteristics in metastatic neuroendocrine tumors of gastric origin

Introduction: Gastric neuroendocrine tumors are also termed gastric carcinoids (GC) and are generally divided in to 3 types. Type 1 are associated with atrophic gastritis and pernicious anaemia, they tend to be multifocal and said not to metastasise. Type 2 GCs are driven by a gastrinomas and tend to be multifocal also. Type 3 are said to be random, solitary, and have a high risk of metastasising.

Conference:

Presenting Author:

Authors: Vickrage S, Humphries S, Coldham C, Shah T,

Keywords: gastric NET, gastric carcinoid, type 1 gastric carcinoid, type 3 gastric carcinoid,

#3517 The role of the NET clinical nurse specialist in managing carcinoid heart disease patients: Optimising patient care

Introduction: The diagnosis of carcinoid heart disease (CHD) is often made late and requires a highly experienced team to manage multiple issues, such as heart failure, carcinoid symptoms and poor nutrition. Prior to December 2018 NET (Neuroendocrine Tumor) and cardiac teams were working in isolation, this resulted in missed opportunities for intervention and comprehensive review. It was evident we needed to build closer collaborations with our cardiac colleagues, to ensure timely assessment, optimisation of symptoms and improve patients’ overall experience. The Clinical Nurse Specialists (CNSs) were fundamental in establishing a twice monthly CHD/NET multidisciplinary team meeting and monthly joint NET/CHD clinic. Patients were kept informed at each stage by the CNS, either during telephone consultation, ward visit or at clinic appointments.

Conference:

Presenting Author:

Authors: Smith S, Vickrage S, Kemp-Blake J, Coldham C, Shah T,

Keywords: Carcinoid Heart Disease, Multidisciplinary team, Clinical Nurse Specialist,

#3485 Small Bowel NET – Is it better to be diagnosed after long-term symptoms or acutely?

Introduction: NET patients present in many different ways and those with small bowel NET can have a particularly difficult journey to diagnosis. If this leads to a delayed diagnosis, does this also mean poorer survival and outcomes compared to those who present in another manner?

Conference:

Presenting Author:

Authors: Coldham C, Humphries S, Shah T,

Keywords: small bowel NET presentation, small bowel NET outcome,

#1654 A Single Centre Analysis of the Management of Appendiceal Neuroendocrine Neoplasms (NENs) Including Goblet Cell Carcinoids (GCC)

Introduction: Appendiceal neuroendocrine neoplasms (NENs) are usually diagnosed incidentally on histology following an appendicectomy. They include carcinoid tumours (appendiceal neuroendocrine tumours, NETs) and goblet cell carcinoids (GCC). GCC neoplasms are able to transform to an adenocarcinoma phenotype.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Sagar V, Coldham C, Shetty S, Elshafie M, Taniere P,

Keywords: Appendiceal neoplasm, neuroendocrine tumors,